News

The Spectator Australia14hOpinion
Australia’s nuclear blind spot
The GenCost 2024-25 report, published annually by CSIRO in partnership with the Australian Energy Market Operator (AEMO), has ...
Vietnam Investment Review on MSN1h
Luye Pharma Begins Phase 1 Trial for Triple-Target Antidepressant
The Phase 1 clinical trial recently initiated in China is a single-center, randomized, double-blind, placebo-controlled, dose ...
China Daily Global Edition4h
A decade in the making, dictionary mirrors shifts in language and culture
After a decade-long revision, the third edition of The English-Chinese Dictionary has returned — bigger, sharper, and more ...
Altria Continues to Expand Operating Margins Even as Cigarette Volumes Continue Secular Decline
Altria dominates the US, its predominant market where cigarette volumes declined 6% per year from 2019 to 2024, faster than the global market's 1% annual loss, according to Euromonitor. Moreover, ...
The Malaysian Reserve18h
First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR
Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for ...